82 related articles for article (PubMed ID: 11208835)
21. Overview of Current and Future Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma.
Nandagopal L; Naik G; Sonpavde G
Curr Treat Options Oncol; 2018 Jan; 19(1):2. PubMed ID: 29349592
[TBL] [Abstract][Full Text] [Related]
22. Renal cell carcinoma: An update for the practicing urologist.
Pal SK; Bergerot P; Figlin RA
Asian J Urol; 2015 Jan; 2(1):19-25. PubMed ID: 29264115
[TBL] [Abstract][Full Text] [Related]
23. Improving outcomes in high-risk, nonmetastatic renal cancer: new data and ongoing trials.
Blick C; Ritchie AWS; Eisen T; Stewart GD
Nat Rev Urol; 2017 Dec; 14(12):753-759. PubMed ID: 28762388
[TBL] [Abstract][Full Text] [Related]
24. Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
Wang Z; Liu N; Gan W; Li X; Zhang G; Li D; Guo H
J Int Med Res; 2017 Aug; 45(4):1287-1296. PubMed ID: 28587544
[TBL] [Abstract][Full Text] [Related]
25. Immunotherapy for metastatic renal cell carcinoma.
Unverzagt S; Moldenhauer I; Nothacker M; Roßmeißl D; Hadjinicolaou AV; Peinemann F; Greco F; Seliger B
Cochrane Database Syst Rev; 2017 May; 5(5):CD011673. PubMed ID: 28504837
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials.
Lenis AT; Donin NM; Johnson DC; Faiena I; Salmasi A; Drakaki A; Belldegrun A; Pantuck A; Chamie K
J Urol; 2018 Jan; 199(1):43-52. PubMed ID: 28479237
[TBL] [Abstract][Full Text] [Related]
27. Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?
Taguchi S; Buti S; Fukuhara H; Otsuka M; Bersanelli M; Morikawa T; Miyazaki H; Nakagawa T; Fujimura T; Kume H; Igawa Y; Homma Y
PLoS One; 2017; 12(2):e0172341. PubMed ID: 28241027
[TBL] [Abstract][Full Text] [Related]
28. Sunitinib in the treatment of metastatic renal cell carcinoma.
Schmid TA; Gore ME
Ther Adv Urol; 2016 Dec; 8(6):348-371. PubMed ID: 27904651
[TBL] [Abstract][Full Text] [Related]
29. Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine.
Wittke S; Baxmann S; Fahlenkamp D; Kiessig ST
Onco Targets Ther; 2016; 9():523-37. PubMed ID: 26889089
[TBL] [Abstract][Full Text] [Related]
30. Systemic adjuvant therapies in renal cell carcinoma.
Buti S; Bersanelli M; Donini M; Ardizzoni A
Oncol Rev; 2012 Oct; 6(2):e18. PubMed ID: 25992216
[TBL] [Abstract][Full Text] [Related]
31. Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.
Rendon RA; Kapoor A; Breau R; Leveridge M; Feifer A; Black PC; So A
Can Urol Assoc J; 2014 May; 8(5-6):E398-412. PubMed ID: 25024794
[No Abstract] [Full Text] [Related]
32. Adjuvant therapy for renal cell carcinoma: past, present, and future.
Pal SK; Haas NB
Oncologist; 2014 Aug; 19(8):851-9. PubMed ID: 24969163
[TBL] [Abstract][Full Text] [Related]
33. Recent developments in the treatment of renal cell carcinoma.
Dutcher JP
Ther Adv Urol; 2013 Dec; 5(6):338-53. PubMed ID: 24294292
[TBL] [Abstract][Full Text] [Related]
34. The prospects of pazopanib in advanced renal cell carcinoma.
Gupta S; Spiess PE
Ther Adv Urol; 2013 Oct; 5(5):223-32. PubMed ID: 24082917
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant therapy in renal cell carcinoma-past, present, and future.
Janowitz T; Welsh SJ; Zaki K; Mulders P; Eisen T
Semin Oncol; 2013 Aug; 40(4):482-91. PubMed ID: 23972712
[TBL] [Abstract][Full Text] [Related]
36. Renal cell cancer: what can we learn from pre-operative studies?
Fisher R; Larkin J
Front Oncol; 2011; 1():51. PubMed ID: 22655250
[No Abstract] [Full Text] [Related]
37. Randomized controlled study of natural interferon α as adjuvant treatment for stage II or III renal cell carcinoma.
Hinotsu S; Kawai K; Ozono S; Tsushima T; Tokuda N; Nomata K; Naito S; Akaza H
Int J Clin Oncol; 2013 Feb; 18(1):68-74. PubMed ID: 22068465
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant and neoadjuvant therapy in renal cell carcinoma.
Choueiri M; Tannir N; Jonasch E
Curr Clin Pharmacol; 2011 Aug; 6(3):144-50. PubMed ID: 21827393
[TBL] [Abstract][Full Text] [Related]
39. Systemic therapy for advanced renal cell carcinoma.
Larkin JM; Kipps EL; Powell CJ; Swanton C
Ther Adv Med Oncol; 2009 Jul; 1(1):15-27. PubMed ID: 21789110
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant therapy for locally advanced renal cell cancer: a systematic review with meta-analysis.
Scherr AJ; Lima JP; Sasse EC; Lima CS; Sasse AD
BMC Cancer; 2011 Mar; 11():115. PubMed ID: 21453469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
